TCTR20150803003招募中4 期
Efficacy of botulinum toxin in pediatric spasticity: a randomized trial comparing 2- to 4- sites hamstring injection
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 Years 至 7 Years(—)
- 性别
- All
入选标准
- •Cerebral palsy children who have spasticity Modified Ashworth Scale-Bohannon (MAS-B) score 1+, 2 and 3 in Hamstring muscles
排除标准
- •1. surgery or accident in lower extremities muscles before.
- •2. injected with Botulinum toxin six months before joining the study.
- •3. allergic to the components of the Botulinum toxin.
- •4. have Neuromuscular disease such as Myasthenia gravis and Eaton Lambert syndrome or on the medication that affects the use of botulinum toxin.
- •5. have an easily bleeding tendency disease or on an anti-blood clotting medication.
研究者
相似试验
已完成
不适用
Botulinum Toxin in the management of spasticity in children with cerebral palsy: a randomised double blind trialCerebral palsyNervous System DiseasesISRCTN85066174HS R&D Regional Programme Register - Department of Health (UK)
已完成
3 期
BOTOX® Treatment in Pediatric Upper Limb SpasticityPediatricsMuscle SpasticityStrokeCerebral PalsyNCT01603602Allergan235
进行中(未招募)
1 期
Treatment of Spasticity in the upper limb in childrepper limb spasticityMedDRA version: 14.1Level: PTClassification code 10028335Term: Muscle spasticitySystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.1Level: LLTClassification code 10048970Term: Arm spasticitySystem Organ Class: 10029205 - Nervous system disordersEUCTR2012-000043-27-DEAllergan Limited412
进行中(未招募)
1 期
Treatment of Spasticity in the upper limb in childrepper Limb Spasticity.MedDRA version: 15.1Level: PTClassification code 10028335Term: Muscle spasticitySystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 15.1Level: LLTClassification code 10048970Term: Arm spasticitySystem Organ Class: 10029205 - Nervous system disordersEUCTR2012-000062-38-DEAllergan Limited412
进行中(未招募)
1 期
Treatment of Spasticity in the upper limb in childreEUCTR2012-000043-27-PLAllergan Limited213
